2021 – 9th Annual Conference & Guest Speakers

 

 

 

 

 

 

Save the Dates!

November 4 – 5, 2021

Thursday, November 4th
Day 1 – Conference Opens at 10:00 a.m. EST
Day 1 – Conculides at 3:30 p.m. EST

Friday, November 5th
Day 2 – Conference Opens at 10:00 a.m. EST
Day 2 – Conference Concludes at 3:30 p.m. EST

Registration is Complimentary This Year and Will Open On March 15th.

……………………………………………………………………..

Welcome Keynote Speakers……….

Stuart B. Johnson, MD, FIDSA, DTM&H
Conference Co-Chair & Keynote Speaker
Dr. Johnson, MD, FIDSA, DTM&H, Professor, Department of Medicine, Stritch School of Medicine, Loyola University, Chicago, IL. Dr. Stuart Johnson, MD is a Professor of Medicine at Loyola University Stritch School of Medicine at Loyola University Medical Center and a Researcher at the Hines VA Hospital, Chicago, Illinois. His main research interest and focus have involved the epidemiology pathogenesis and treatment of Clostridium difficile infection. He is actively studying variant strains of C. difficile and the role of the various toxins in the pathogenesis of C. difficile disease. His clinical experience in the treatment of patients with recurrent CDI has translated into studies helping to define optimal management of these infections, including the utility and pitfalls of alternative treatment agents. He is currently the Principal Investigator of a multi-center study with the VA Healthcare system designed to define optimal management of early
recurrences of CDI.
Presentation Topic: TBA

Paul Feuerstadt, MD, FACG
Conference Co-Chair & Keynote Speaker
Dr. Feuerstadt, MD, FACG,  is a Native of Long Island, New York.
Dr. Feuerstadt attended the University of Pennsylvania where he earned his Bachelor of Arts degree in Biology, with distinction in research, and graduated Summa Cum Laude. Following the completion of his undergraduate training, Dr. Feuerstadt attended the Weill Medical College of Cornell University in Manhattan, New York where he earned his Medical Doctor degree and stayed at New York-Presbyterian Hospital/Weill Cornell medical center for his internship and residency in Internal Medicine. Following the completion of his residency, Dr. Feuerstadt then moved on to the Montefiore Medical Center in the Bronx, NY for his clinical fellowship training. His areas of interest include ischemic diseases of the gut and chronic diarrheal syndromes with a specific focus on C.diff. infections. Dr.Feuerstadt is affiliated with the St. Raphael campus of Yale-New Haven Hospital, Yale-New Haven Hospital, and Milford Hospital seeing outpatients in his offices in Hamden & Milford, CT
Presentation Topic: TBA

Dale Gerding, MD, FACP, FIDSA
Keynote Speaker

Dr. Gerding, MD, FACP, FIDSA, Professor of Medicine at Loyola University Chicago Stritch School of Medicine in Maywood, Illinois, and Research Physician at the Edward Hines Jr. VA Hospital. Before his present position, Dr. Gerding was Chief of Medicine at VA Chicago, Lakeside Division, and Professor of Medicine at Northwestern University Feinberg School of Medicine. He is an infectious disease specialist and hospital epidemiologist, past president of the Society for Healthcare Epidemiology of America (SHEA), and past chair of the antibiotic resistance committee of SHEA. He is a fellow of the Infectious Diseases Society of America (IDSA) and past Chair of the National and Global Public Health Committee and the Antibiotic Resistance Subcommittee of IDS   
Presentation Topic:
   TBA

Professor Mark Wilcox, MD, FRCPath Dr. Wilcox is the Consultant Microbiologist, Head of Microbiology and Academic Lead of Pathology at the Leeds Teaching Hospitals (LTHT), Professor of Medical Microbiology at the University of Leeds at their Institute of Biomedical and Clinical Sciences, and is the lead on Clostridium difficile for Public Health, in England in the UK. He was Director of Infection Prevention, and Control, Doctor and Clinical Director of Pathology at LTHT. Dr. Wilcox is deputy Chair of the UK Department of Health’s Antimicrobial Resistance and Healthcare-Associated Infection Committee and is a member of the HPA’s Program Board on Healthcare-Associated Infection & Antimicrobial Resistance. He has a track record of translational research, including providing the basis of clinical advice to the NHS. He has been the Principal/UK Investigator for several clinical trials of new anti-infective drugs and has provided clinical advice as part of the FDA/EMA submissions for the approval of several novel antimicrobial agents. 
Presentation Topic:  TBA

Caterina Oneto, MD C. diff. Global TeleSupport Program, Co-Director      Dr. Caterina Oneto is a Clinical Instructor within the NYU Division of Gastroenterology, Board Certified in Gastroenterology and Internal Medicine.  Dr. Oneto is fluent in Spanish.  She graduated with a degree in Medicine and Surgery from the Universidad de Valparaiso in Chile and completed her residency in Internal Medicine at Cabrini Medical Center, where she served also as  Chief Resident, and later completed her Fellowship in Gastroenterology at Montefiore Medical Center, Albert Einstein College of Medicine. With expertise in endoscopy, colonoscopy, capsule endoscopy, liver, and pancreatic diseases, Dr. Oneto’s special interests include IBD  (Crohn’s disease and Ulcerative Colitis), IBS (irritable bowel syndrome), microbiota modification, treatment of  Clostridioides difficile, and FMT (Fecal Microbiota Transplantation).
Presentation Topic:  TBA


Nicola Petrosillo, MD
Dr. Nicola Petrosillo earned a degree of  Doctor in Medicine and Surgery from the University “La Sapienza” in Rome, Italy in 1977; in the same University, he became a specialist in Infectious Diseases (1981) and in Internal Medicine (1985). In 1981, he became hospital infectious diseases registrar and in 1999 Director of an Infectious Diseases Division at the National Institute for Infectious Diseases “Lazzaro Spallanzani” of Rome, Italy. He is a fellow of the Pulmonary Vascular Research Institute and leader of the international task force for pulmonary hypertension associated with HIV, since 2007. He is a member of the Professional Affairs SubCommittee on Infectious Diseases and a member of the Advisory Board of the Trainee Association of ESCMID. Additionally, he is a Professor of Infectious Diseases at the Medical School of Specialization in Hygiene of the Tor Vergata University, Rome.
Presentation Topic: TBA

Tamas Haidegger, Ph. D.Tamás Haidegger received his MSc degrees from the Budapest University of Technology and Economics (BME) in Electrical Engineering and Biomedical Engineering, then Ph.D. in medical robotics. Currently, he is an associate professor at Óbuda University, serving as the director of the University Research and Innovation Center (EKIK), and as the technical lead of medical robotics research.
Presentation Topic: TBA

 

David Lyerly, Ph.D. is the co-founder and Chief Science Officer of  TECHLAB, Inc.  He received his B.S. from UNC-Chapel Hill and his Ph.D.  in Microbiology/Immunology from Wake Forest Bowman Gray School of  Medicine.  He and Dr. Tracy Wilkins founded TECHLAB in 1989.  TECHLAB  focuses on innovative diagnostic solutions for  C. difficile, other enteric diseases, and intestinal inflammation.

Barbara McGovern, MD
Dr. Barbara McGovern is VP, Medical Affairs of Seres. Dr. McGovern has over 25 years of experience in infectious diseases. Prior to joining Seres, she served as Medical Director in the Medical Affairs Division at AbbVie and helped to launch Viekera Pak for treatment of Hepatitis C virus (HCV) infection. At AbbVie, Dr. McGovern was a recipient of the 2015 President’s Award in recognition of the successful execution of 7 major publications in the New England Journal of MedicineLancet, and JAMA. As an academic clinician at Tufts Medical Center, she also authored more than 50 journal articles, editorials, and textbook chapters on HIV and HCV and was an Associate Editor of Clinical Infectious Diseases and a Deputy Editor at Up-To-Date.

Maureen Spencer, RN, M.Ed. CIC has been an Infection  Preventionist for over 40 years and is board certified in infection control (CIC). As one of the early pioneers in infection control, she was awarded the APIC National Carole DeMille Award in 1990 and was selected as one of the APIC Heroes of Infection Prevention in 2007 for her work in establishing a MRSA and Staph aureus Elimination Program at  New England Baptist Hospital, an Orthopedic Center of Excellence in  Boston. The groundbreaking work was published in the Journal of Bone and  Joint Surgery, Aug 2010.  In 2012 she was selected as one of the  “Who’s Who of Infection Prevention” and in 2017 she was recognized as a  Fellow of the Association for Professionals in Infection Control and  Epidemiology (FAPIC) for her advanced practice in infection prevention and leader within the field.   

 

……………Confirmed To-Date………………

 

S P O N S O R S

To learn more about the Sponsors, please click on the graphics displayed below.  Thank you.

 

 

 

 

 

 

 

 

Check Back For Keynote Speakers, On-Demand Poster Presentations, Sponsors, and Conference Updates!